These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 8408470)

  • 1. Bone metabolic activity measured with positron emission tomography and [18F]fluoride ion in renal osteodystrophy: correlation with bone histomorphometry.
    Messa C; Goodman WG; Hoh CK; Choi Y; Nissenson AR; Salusky IB; Phelps ME; Hawkins RA
    J Clin Endocrinol Metab; 1993 Oct; 77(4):949-55. PubMed ID: 8408470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of porcine bone metabolism by dynamic.
    Piert M; Zittel TT; Becker GA; Jahn M; Stahlschmidt A; Maier G; Machulla HJ; Bares R
    J Nucl Med; 2001 Jul; 42(7):1091-100. PubMed ID: 11438633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of risedronate on regional bone metabolism and blood flow at the lumbar spine measured by 18F-fluoride positron emission tomography.
    Frost ML; Cook GJ; Blake GM; Marsden PK; Benatar NA; Fogelman I
    J Bone Miner Res; 2003 Dec; 18(12):2215-22. PubMed ID: 14672357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone disease in renal failure. Clinical and histomorphometric studies.
    Nilsson P
    Scand J Urol Nephrol Suppl; 1984; 84():1-68. PubMed ID: 6393322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal osteodystrophy: alpha-Heremans Schmid glycoprotein/fetuin-A, matrix GLA protein serum levels, and bone histomorphometry.
    Coen G; Ballanti P; Balducci A; Grandi F; Manni M; Mantella D; Pierantozzi A; Ruggeri M; Sardella D; Sorbo G; Bonucci E
    Am J Kidney Dis; 2006 Jul; 48(1):106-13. PubMed ID: 16797392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients.
    Moore C; Yee J; Malluche H; Rao DS; Monier-Faugere MC; Adams E; Daramola-Ogunwuyi O; Fehmi H; Bhat S; Osman-Malik Y
    Clin J Am Soc Nephrol; 2009 Sep; 4(9):1484-1493. PubMed ID: 19713297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone disease in patients with long-term renal transplantation and normal renal function.
    Carlini RG; Rojas E; Weisinger JR; Lopez M; Martinis R; Arminio A; Bellorin-Font E
    Am J Kidney Dis; 2000 Jul; 36(1):160-6. PubMed ID: 10873886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary hyperparathyroidism in chronic renal failure.
    Malmaeus J
    Scand J Urol Nephrol Suppl; 1983; 70():1-63. PubMed ID: 6351238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term treatment of secondary hyperparathyroidism in the chronic hemodialysis patient with 1,25-(OH)2D3].
    Giachino G; Giacchino F; Jeantet A; Del Piano A; Garetto A; Pellerey M; Piccoli G
    Minerva Med; 1985 Mar; 76(9-10):407-14. PubMed ID: 2984605
    [No Abstract]   [Full Text] [Related]  

  • 10. Refractory renal hyperparathyroidism: clinical features and outcome of surgical therapy.
    McHenry CR; Wilhelm SM; Ricanati E
    Am Surg; 2001 Apr; 67(4):310-6; discussion 316-7. PubMed ID: 11307995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of renal osteopathy in patients with chronic dialysis].
    Kiss D; Brunner FP
    Schweiz Med Wochenschr; 1996 Oct; 126(42):1792-8. PubMed ID: 8966512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressive effect of calcium on parathyroid hormone release in adynamic renal osteodystrophy and secondary hyperparathyroidism.
    Goodman WG; Veldhuis JD; Belin TR; Juppner H; Salusky IB
    Kidney Int; 1997 May; 51(5):1590-5. PubMed ID: 9150477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
    Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S
    Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can bone histomorphometry be predicted by clinical assessment and noninvasive techniques in peritoneal dialysis?
    Joffe P; Heaf JG; Jensen C
    Miner Electrolyte Metab; 1996; 22(4):224-33. PubMed ID: 8807626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitriol may directly suppress bone turnover.
    Ureña P; Prieur P; Pétrover M
    Nephron; 1997; 75(1):116-7. PubMed ID: 9031288
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy.
    Mazzaferro S; Pasquali M; Ballanti P; Bonucci E; Costantini S; Chicca S; De Meo S; Perruzza I; Sardella D; Taggi F
    Nephrol Dial Transplant; 1995; 10(1):52-8. PubMed ID: 7724029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of new markers of bone metabolism in renal osteodystrophy in children].
    Deschenes G; Souberbielle JC; Brunelle F; Dechaux M
    Ann Pediatr (Paris); 1990 Feb; 37(2):120-2. PubMed ID: 2181914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgically induced uremia in rats. I: Effect on bone strength and metabolism.
    Jablonski G; Klem KH; Attramadal A; Dahl E; Rønningen H; Gautvik KM; Haug E; Gordeladze JO
    Biosci Rep; 1993 Oct; 13(5):275-87. PubMed ID: 8142613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micro-CT in the Assessment of Pediatric Renal Osteodystrophy by Bone Histomorphometry.
    Pereira RC; Bischoff DS; Yamaguchi D; Salusky IB; Wesseling-Perry K
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):481-7. PubMed ID: 26712809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased mineralization in hemodialysis patients after subtotal parathyroidectomy.
    Weinstein RS
    Calcif Tissue Int; 1982 Jan; 34(1):16-20. PubMed ID: 6802455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.